Published in Thrombosis on December 16, 2013
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med (2002) 2.16
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg (1995) 1.76
Low molecular weight heparin. Blood (1992) 1.74
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br (2006) 1.56
Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand (2000) 1.42
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Posttrauma coagulation and fibrinolysis. Crit Care Med (1992) 1.19
Short- and long-term mortality following primary total hip replacement for osteoarthritis: a Danish nationwide epidemiological study. J Bone Joint Surg Br (2011) 1.17
The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res (1995) 1.14
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost (2010) 1.08
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest (2003) 1.08
The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2. J Biol Chem (1979) 1.08
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med (2001) 1.00
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost (1991) 0.96
Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med (1995) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Physicians' perceptions of the definition of major bleeding in major orthopedic surgery: results of an international survey. J Thromb Thrombolysis (2011) 0.90
Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thromb Res (1991) 0.90
Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis. Clin Orthop Relat Res (2012) 0.88
Preoperative versus postoperative initiation of dalteparin thromboprophylaxis in THA. Hip Int (2010) 0.85
Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis. Semin Thromb Hemost (2004) 0.84
Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement. Thromb Haemost (1998) 0.84
Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement. Anesthesiology (1999) 0.83
Thrombosis markers in hip versus knee arthroplasty: a pilot study. J Orthop Surg (Hong Kong) (2009) 0.80
Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group. Thromb Res (1990) 0.79
Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Thromb Haemost (1999) 0.79
Efficacy and safety of a perioperative enoxaparin regimen in total hip replacement under various anesthesias. Am J Surg (1991) 0.77
[Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation]. Rev Esp Anestesiol Reanim (2012) 0.77
Studies on coagulation, fibrinolysis, kallikrein-kinin and complement activation in systemic and pulmonary circulation during hip arthroplasty with acrylic cement. Thromb Res (1988) 0.76